Harmony Biosciences (NASDAQ:HRMY) Receives “Buy” Rating from Needham & Company LLC
Needham & Company LLC reissued their buy rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research report report published on Tuesday,Benzinga reports. The firm currently has a $50.00 price target on the stock. Several other equities research analysts have also weighed in on the company. Deutsche Bank Aktiengesellschaft initiated coverage on […]
Needham & Company LLC reissued their buy rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research report report published on Tuesday,Benzinga reports. The firm currently has a $50.00 price target on the stock. Several other equities research analysts have also weighed in on the company. Deutsche Bank Aktiengesellschaft initiated coverage on […]
